January 2010

We applied our EASANA® platform to analyze the splicing factor expression and transcriptome among 11 normal human tissues using the Affymetrix Exon Arrays (collaboration with INSERM). Article “Splicing factor and exon profiling across human tissues.” de la Grange P, Gratadou L, Delord M, Dutertre M, Auboeuf D. Nucleic Acids Res. Read more…

We applied our EASANA® platform to identify regulated exons between mammary gland primary tumors with different metastatic property. Expression of the subsequent validated splicing variants was then correlated with prognosis of breast cancer patients through restrospective study (collaboration with INSERM, CNRS and the Curie Institute). Article “Exon-based clustering of murine Read more…